Related Experiment Video

Updated: Aug 14, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

[Free radical oxidation in patients with hypertrophic cardiomyopathy]

V A Liusov, Iu A Gomzikova

    Terapevticheskii Arkhiv
    |January 1, 1997
    PubMed

    Insights

    This study on hypertrophic cardiomyopathy (HC) found that natural antioxidants improved patient outcomes, reducing arrhythmia and enhancing exercise tolerance. Combining antioxidants with standard treatments yielded even better results for managing this heart condition.

    Area of Science:

    • Cardiology
    • Biochemistry
    • Oxidative Stress Research

    Background:

    • Non-obstructive hypertrophic cardiomyopathy (HC) is linked to increased reactive oxygen species production by leukocytes.
    • Patients with HC exhibit altered enzyme activity in antioxidant defense systems.
    • Despite oxidative stress, lipid peroxidation remains unchanged, while total plasma antioxidant activity is elevated.

    Purpose of the Study:

    • To investigate the effects of natural antioxidants and glutamic acid on patients with non-obstructive hypertrophic cardiomyopathy (HC).
    • To assess the impact of antioxidant therapy on clinical response, cardiac arrhythmia, and exercise tolerance in HC patients.

    Main Methods:

    • A study involving 27 patients diagnosed with non-obstructive hypertrophic cardiomyopathy (HC).
    • Administration of a complex of natural antioxidants with varied mechanisms of action, alongside glutamic acid.
    • Evaluation of clinical response, incidence of cardiac arrhythmia, and exercise tolerance.

    Main Results:

    • The antioxidant complex and glutamic acid led to subjective clinical improvements in HC patients.
    • A reduced incidence of cardiac arrhythmia was observed following the antioxidant treatment.
    • Patients experienced enhanced exercise tolerance after receiving the antioxidant intervention.
    • Combined therapy of antioxidants with conventional treatments resulted in superior clinical outcomes.

    Conclusions:

    • Natural antioxidants, in combination with glutamic acid, demonstrate a beneficial effect in managing non-obstructive hypertrophic cardiomyopathy (HC).
    • Antioxidant therapy can effectively mitigate cardiac arrhythmia and improve functional capacity in HC patients.
    • Integrating antioxidant interventions with standard therapeutic approaches offers a promising strategy for enhanced hypertrophic cardiomyopathy management.

    More Related Videos

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

    Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

    Published on: May 26, 2023

    Related Concept Videos

    Radical Autoxidation01:20

    Radical Autoxidation

    The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...